Skip to main content
Springer logoLink to Springer
. 2026 Jun 5;34(7):617. doi: 10.1007/s00520-026-10851-3

Telehealth service use in people with cancer compared to people without cancer: analysis of Patient Experience Surveys in Australia

Huah Shin Ng 1,2,3,✉, Ramya Walsan 3, Reema Harrison 3, Bogda Koczwara 1,4
PMCID: PMC13241413  PMID: 42247164

Abstract

Purpose

To compare the prevalence and characteristics associated with telehealth use in people with and without cancer.

Methods

Cross-sectional study using data from the Australia’s Patient Experience Surveys (2022–2023 and 2023–2024) of all participants aged ≥ 25 years. Multivariable logistic regression analyses were performed to examine characteristics associated with telehealth use between cancer and non-cancer groups and to compare self-assessed health status, emergency department (ED) presentation and hospitalisations by telehealth use and cancer status.

Results

Telehealth was used by over one-third of respondents with cancer (n = 797/2109, 38%) and one-quarter of respondents without cancer (n = 11,984/45,438; 26%). In both cancer and non-cancer groups, mental health conditions and other long-term health conditions were associated with higher odds of telehealth use, whereas being unmarried, uninsured, having a lower education level and a more recent survey were associated with lower odds of telehealth use. The odds of poor health status (adjusted odds ratio (aOR) = 4.29; 95% CI = 3.59–5.12), ED presentation (aOR = 2.69; 95% CI = 2.30–3.14) and hospital admission (aOR = 3.97; 95% CI = 3.41–4.61) were highest in people with cancer and telehealth use, followed by people with cancer who did not use telehealth and people without cancer who use telehealth, when compared to people without cancer and telehealth usage. Over 90% of people who used telehealth showed positive perceptions of the service regardless of cancer status.

Conclusions

While over one-third of respondents with cancer utilised a telehealth service, the majority did not. Further research should investigate the barriers to accessing telehealth services to inform the development of health policy and strategies targeting people with greatest needs.

Keywords: Cancer, Perceptions, Telehealth, Health service, Australia

Introduction

Telehealth or telemedicine involves a consultation with a health professional over the phone, by video conferencing or through other telecommunication technologies to deliver various aspects of healthcare such as diagnosis, treatment, prevention and monitoring [1, 2]. The provision of telehealth services has the potential to improve healthcare access due to geographical barriers, reducing the need for long distance travel and associated time and travel costs for patients living in rural and remote areas [3]. Telehealth service also offers an alternative way of delivering care to patients with chronic diseases that require regular monitoring and follow-up, providing some flexibility with appointment scheduling that fit patients’ preferences [3].

In Australia, patient access to telehealth services is supported by the ongoing Australian Government’s Medicare Benefits Schedule arrangements as part of the Government’s response to the COVID-19 pandemic [4]. There are specific geographical requirements in place such as the provision of service to a patient who is at least 15 km away by road from the healthcare provider at the appointment time or to a patient who is in a telehealth eligible area, although there are exceptions to this rule [5]. While telehealth has existed for a long time in Australia, its extent of use has been constrained primarily to rural and remote settings [6, 7]. Telehealth was also understudied until the COVID-19 pandemic, during which the restrictions on isolation and physical distancing rules have led to a fast evolution in the availability of telehealth services [6].

Telehealth has been particularly beneficial for people with cancer during the COVID-19 pandemic due to increased risk of adverse outcomes from infections in immunocompromised patients [8]. A scoping review of the use of telehealth technology in people with cancer during the COVID-19 pandemic included 29 studies from across the USA, the UK, Italy, Australia, Saudi Arabia, China and Canada [9]. The results of the review showed that various telehealth technology including video conferencing, telephone consultation and messaging applications were being widely used by people with cancer for teleconsultation, televisit, telerehabilitation and telemonitoring [9]. The study showed positive outcomes in terms of users’ satisfaction with the telehealth services [9]. While an Australian study of nearly 40,000 people accessing cancer services showed that those who used telehealth services had higher odds of emergency department (ED) visits and unplanned hospitalisation [10], whether these outcomes differ between people with and without cancer or with other chronic diseases and the sociodemographic and comorbidity characteristics associated with telehealth service use remains to be explored [11]. Identifying predictors associated with higher healthcare service use among people with cancer compared with the general population and quantifying the extent of differences in health status by healthcare service and cancer status could help direct resources and inform planning of future service development. Leveraging technology to access healthcare, particularly for high-need groups, could help improve continuity of care and health outcomes [3].

To address these gaps in knowledge, the aims of this study were to compare the following: (i) the prevalence and characteristics associated with telehealth service use in people with and without cancer, (ii) self-reported health status, visits to ED and hospitalisation by telehealth usage and cancer status and (iii) perceptions of care among those who used telehealth services in people with and without cancer.

Methods

Data source

We used data from the Patient Experience Surveys (PES) conducted by the Australian Bureau of Statistics (ABS) for the last 2 financial years (2023–2024 and 2022–2023) in random samples (generated based on computer algorithm) of people aged ≥ 15 years who were usual residents of private dwellings throughout Australia [12, 13]. Data were collected from participants via telephone interviews about their experiences with a range of healthcare services in the past 12 months before the interview, including general practitioners, specialists, hospitals, ED and telehealth services. Data were collected from 26,176 people in 2023–2024 PES and 25,934 people in 2022–2023 PES. We accessed the de-identified data for analysis through the ABS secure DataLab [14].

Study population

We identified people who self-reported of having cancer as one of the long-term health conditions as the cancer group and the remaining participants as the non-cancer group. We restricted our study population to people aged ≥ 25 years as the healthcare needs in adolescents and young adults (described as 15–24 years in Australia) with cancer may be distinct from those in adults [15].

Telehealth services

Participants were asked if they had used a telehealth service (i.e. appointments with a health professional over the phone, by video conferencing or through other communication technologies) for their own health in the last 12 months, and the types of health professionals they had the telehealth services with. For those who had a telehealth service, their perceptions of the service were collected in the PES using a 5-point scale (always, often, sometimes, rarely or never), including if all the telehealth practitioners they had seen: (1) listened carefully to them; (2) showed respect for what they had to say; (3) spent enough time with them. For the purpose of this study, we grouped the responses into two categories as ‘always/often’ and ‘sometimes/rarely/never’ to meet minimum cell count requirements for data privacy (i.e. no cell contained fewer than 10 observations). Lastly, participants were also asked if they would use telehealth again for consultation (yes or no) if it was offered. For those who had used a telehealth service but were not capable of answering for themselves due to injury, illness or language barriers (i.e. interviews that were conducted by proxy), they were not asked these questions related to their perceptions of the service.

Sociodemographic and other long-term health conditions

Sociodemographic information including sex, age (grouped as < 50, 50–65, 65–79 and ≥ 80 years); country of birth (Australia, main English-speaking countries, others); geographical location (major cities or others); marital status (married or not married); employment status (employed or unemployed/not in labour force); highest education level (postgraduate, bachelor’s degree, diploma, certificate or no non-school qualification/missing data); socioeconomic status (measured by the index of relative socioeconomic disadvantage 2016) [16] and the private health insurance status were extracted.

Participants were asked whether they have any of the following individual long-term health conditions that have lasted, or are likely to last, for 6 months or more: (1) arthritis or osteoporosis, (2) asthma, (3) diabetes, (4) heart or circulatory condition, (5) mental health condition including depression or anxiety, (6) long-term injury or (7) any other long-term health conditions.

Self-assessed health status, and use of ED services and hospitalisations

Self-assessed health status was collected in the PES whereby participants were asked ‘In general, would you say that your health is excellent, very good, good, fair or poor?’ We grouped the responses into two categories: (1) good health comprising rating of excellent, very good or good health status, and (2) poor health comprising rating of fair or poor health status [17].

We also analysed the data on whether the participants had been to a hospital ED (yes or no) and had been admitted to hospital (yes or no) in the past 12 months.

Statistical analysis

Descriptive analysis was conducted to summarise the characteristics of the study population by telehealth service use and cancer status. We conducted separate multivariable logistic regression analyses to examine the characteristics associated with the use of telehealth service in the overall study population, those with cancer, and those without cancer. Characteristics considered were sociodemographic factors (sex, age, country of birth, geographical location, marital status, employment status, education level, socioeconomic status and private health insurance status), presence of selected individual types of long-term health conditions, and the year of PES (2023–2024 or 2022–2023). The results were reported as adjusted odds ratio (aOR) with 95% confidence intervals (CIs).

We also compared self-assessed health status, use of ED services and hospitalisations by telehealth service use and cancer status using multivariable logistic regression. The models were adjusted for sociodemographic factors, presence of selected individual types of long-term health conditions and year of PES as described above.

For those who had a telehealth service and provided opinions on their perceptions of the service, descriptive analysis was performed to compare their responses between people with and without cancer.

All analyses were conducted using R version 4.4.1.

Ethics approval

This study was approved by the Flinders University Human Research Ethics Committee Low Risk Panel (#7218) and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.

Results

Cohort characteristics

A total of 47,547 people aged ≥ 25 years from across the two PES were included in the cross-sectional analysis (Table 1). Of these, 2109 people were identified as having a cancer and the remaining 45,438 people as the non-cancer group. Over one-third of people with cancer (n = 797, 38%) and one-quarter of people without cancer (n = 11,984; 26%) had a telehealth service in the past 12 months. The proportion of people with telehealth was higher in the 2022–23 PES than the 2023–24 PES in both cancer (40% vs 35%) and non-cancer groups (28% vs 24%). About half of the people who had a telehealth service were aged < 50 years in the non-cancer group and were aged 65–79 years in the cancer group, with similar age distribution between those with and without telehealth service in their respective cancer and non-cancer counterparts.

Table 1.

Characteristics of the study population by cancer status

Characteristics, n (%) Cancer Non-cancer p-valuea
Total n= 2109 Telehealth n= 797 No telehealth n= 1312 Total n= 45,438 Telehealth n= 11,984 No telehealth n= 33,454
Sex
Female 1019 (48) 402 (50) 617 (47) 24,763 (55) 7797 (65) 16,966 (51) < 0.001
Male 1090 (52) 395 (50) 695 (53) 20,675 (45) 4187 (35) 16,488 (49)
Age group, years
< 50 148 (7) 65 (8) 83 (6) 20,559 (45) 5545 (46) 15,014 (45)  < 0.001
50–64 483 (23) 197 (25) 286 (22) 11,360 (25) 2992 (25) 8368 (25)
65–79 1044 (49) 401 (50) 643 (49) 10,350 (23) 2739 (23) 7611 (23)
≥ 80 434 (21) 134 (17) 300 (23) 3169 (7) 708 (6) 2461 (7)
Country of birth
Australia 1578 (75) 622 (78) 956 (73) 30,366 (67) 8720 (73) 21,646 (65)  < 0.001
Main English-speaking 262 (12) 96 (12) 166 (13) 5017 (11) 1285 (11) 3732 (11)
Others 269 (13) 79 (10) 190 (14) 10,055 (22) 1979 (16) 8076 (24)
Geographical location
Major cities 1254 (60) 451 (57) 803 (61) 29,757 (66) 8088 (68) 21,669 (65)  < 0.001
Others 855 (40) 346 (43) 509 (39) 15,681 (34) 3896 (32) 11,785 (35)
Marital status
Married 1104 (52) 443 (56) 661 (50) 25,316 (56) 6611 (55) 18,705 (56) 0.001
Not married 1005 (48) 354 (44) 651 (50) 20,122 (44) 5373 (45) 14,749 (44)
Employment status
Employed 514 (24) 216 (27) 298 (23) 27,759 (61) 7245 (61) 20,514 (61) < 0.001
Unemployed/not in labour force 1595 (76) 581 (73) 1014 (77) 17,679 (39) 4739 (39) 12,940 (39)
Highest education level
Postgraduate 207 (10) 94 (12) 113 (9) 6084 (13) 1983 (17) 4101 (12)  < 0.001
Bachelor’s degree 283 (13) 130 (16) 153 (12) 9185 (20) 2658 (22) 6527 (20)
Diploma 222 (11) 102 (13) 120 (9) 4751 (11) 1330 (11) 3421 (10)
Certificate 448 (21) 163 (20) 285 (22) 9236 (20) 2288 (19) 6948 (21)
No non-school qualification/missing 949 (45) 308 (39) 641 (49) 16,182 (36) 3725 (31) 12,457 (37)
Socioeconomic status
Decile 1–2 471 (22) 178 (22) 293 (22) 8316 (18) 2054 (17) 6262 (19)  < 0.001
Decile 3–4 468 (22) 175 (22) 293 (22) 8838 (20) 2188 (18) 6650 (20)
Decile 5–6 416 (20) 160 (20) 256 (20) 9492 (21) 2546 (21) 6946 (21)
Decile 7–8 390 (19) 150 (19) 240 (18) 9723 (21) 2666 (22) 7057 (21)
Decile 9–10 364 (17) 134 (17) 230 (18) 9069 (20) 2530 (21) 6539 (19)
Private health insurance status
Yes 1248 (59) 505 (63) 743 (57) 27,314 (60) 7773 (65) 19,541 (58) < 0.001
No 861 (41) 292 (37) 569 (43) 18,124 (40) 4211 (35) 13,913 (42)
Long-term health condition
Arthritis/osteoporosis 1054 (50) 423 (53) 631 (48) 10,742 (24) 3596 (30) 7146 (21)  < 0.001
Asthma 331 (16) 129 (16) 202 (15) 4956 (11) 1986 (17) 2970 (9) < 0.001
Diabetes 332 (16) 126 (16) 206 (16) 3604 (8) 1150 (10) 2454 (7) < 0.001
Heart/circulatory condition 788 (37) 315 (40) 473 (36) 8190 (18) 2712 (23) 5478 (16) < 0.001
Mental health condition 453 (22) 200 (25) 253 (19) 7785 (17) 3489 (29) 4296 (13) < 0.001
Long-term injury 373 (18) 161 (20) 212 (16) 4949 (11) 1863 (16) 3086 (9) < 0.001
Other long-term condition 606 (29) 280 (35) 326 (25) 8854 (20) 3451 (29) 5403 (16) < 0.001
Survey year
2022–2023 1051 (50) 423 (53) 628 (48) 22,597 (50) 6431 (54) 16,166 (48)  < 0.001
2023–2024 1058 (50) 374 (47) 684 (52) 22,841 (50) 5553 (46) 17,288 (52)
Types of telehealth professionals N/A N/A N/A N/A
General practitioner 589 (74) 10,194 (85)  < 0.001
Medical specialist 358 (45) 2266 (19)  < 0.001
Nurse 54 (7) 476 (4)  < 0.001
Other health professionals 48 (6) 1022 (9)  < 0.001

aComparisons across four groups (cancer with telehealth, cancer without telehealth, non-cancer with telehealth, and non-cancer without telehealth) for all characteristics, except for types of telehealth professionals with comparisons across two groups (cancer with telehealth and non-cancer with telehealth)

A higher proportion of people used telehealth services was born in Australia (73–78% versus 65–73%) and had a higher education level (61–69% versus 51–63% with a non-school qualification), private insurance (63–65% versus 57–58%) and a long-term health condition (e.g. 25–29% versus 13–19% with a mental health condition) compared to people without a telehealth service in both cancer and non-cancer groups. The most common telehealth professional seen by those with a telehealth service was a general practitioner (74% in cancer versus 85% in non-cancer), followed by a medical specialist (45% in cancer versus 19% in non-cancer).

Characteristics associated with telehealth service use

Several characteristics were associated with a higher likelihood of having had a telehealth service in the past 12 months including presence of cancer (aOR = 1.62, 95% CI = 1.46–1.78) and all the individual types of long-term health conditions (aOR ranged from 1.32 for diabetes to 2.21 for mental health condition) examined in the study (Table 2). Characteristics associated with a lower likelihood of telehealth service were being male, older age, unmarried, unemployed, uninsured, completing the PES survey in a more recent year (i.e. 2023–2024), having been born overseas, resided outside of major cities, and a lower education level. These similar trends were observed in both the overall study population and the non-cancer group.

Table 2.

Characteristics associated with telehealth service use (yes versus no (reference))

Characteristics Adjusted odds ratio (95% CI)
Overall Cancer Non-cancer
Sex
Female Reference Reference Reference
Male 0.61 (0.58–0.64)* 0.84 (0.69–1.02) 0.60 (0.57–0.63)*
Age group, years
< 50 Reference Reference Reference
50–64 0.82 (0.77–0.87)* 0.92 (0.62–1.36) 0.81 (0.76–0.86)*
65–79 0.79 (0.74–0.86)* 0.87 (0.58–1.31) 0.78 (0.72–0.84)*
≥ 80 0.61 (0.55–0.68)* 0.65 (0.41–1.03) 0.61 (0.54–0.68)*
Country of birth
Australia Reference Reference Reference
Main English-speaking 0.86 (0.81–0.93)* 0.92 (0.69–1.22) 0.86 (0.80–0.93)*
Others 0.63 (0.60–0.67)* 0.64 (0.48–0.86)* 0.64 (0.60–0.68)*
Geographical location
Major cities Reference Reference Reference
Others 0.85 (0.81–0.90)* 1.19 (0.98–1.45) 0.84 (0.80–0.88)*
Marital status
Married Reference Reference Reference
Not married 0.89 (0.85–0.93)* 0.80 (0.66–0.97)* 0.90 (0.86–0.94)*
Employment status
Employed Reference Reference Reference
Unemployed/not in labour force 0.93 (0.88–0.99)* 0.89 (0.68–1.15) 0.93 (0.87–0.99)*
Highest education level
Postgraduate Reference Reference Reference
Bachelor’s degree 0.82 (0.76–0.88)* 1.00 (0.69–1.45) 0.81 (0.76–0.88)*
Diploma 0.74 (0.98–0.80)* 0.99 (0.67–1.46) 0.72 (0.66–0.79)*
Certificate 0.64 (0.59–0.69)* 0.66 (0.46–0.94)* 0.64 (0.59–0.69)*
No non-school qualification/missing 0.56 (0.52–0.60)* 0.58 (0.41–0.80)* 0.56 (0.52–0.60)*
Socioeconomic status
Decile 1–2 0.95 (0.88–1.03) 1.23 (0.89–1.70) 0.94 (0.87–1.01)
Decile 3–4 0.96 (0.89–1.03) 1.20 (0.88–1.63) 0.94 (0.88–1.01)
Decile 5–6 1.05 (0.98–1.13) 1.14 (0.84–1.56) 1.05 (0.98–1.12)
Decile 7–8 1.03 (0.97–1.10) 1.16 (0.86–1.58) 1.03 (0.96–1.10)
Decile 9–10 Reference Reference Reference
Private health insurance status
Yes Reference Reference Reference
No 0.78 (0.74–0.82)* 0.80 (0.65–0.98)* 0.78 (0.74–0.81)*
Long-term health conditions
Arthritis/osteoporosis
No Reference Reference Reference
Yes 1.33 (1.25–1.40)* 1.21 (0.99–1.48) 1.35 (1.27–1.43)*
Asthma
No Reference Reference Reference
Yes 1.50 (1.41–1.60)* 0.91 (0.70–1.18) 1.55 (1.45–1.65)*
Diabetes
No Reference Reference Reference
Yes 1.32 (1.22–1.42)* 1.03 (0.79–1.33) 1.36 (1.25–1.47)*
Heart/circulatory condition
No Reference Reference Reference
Yes 1.48 (1.40–1.57)* 1.21 (0.99–1.48) 1.51 (1.42–1.60)*
Mental health condition
No Reference Reference Reference
Yes 2.21 (2.09–2.33)* 1.27 (1.01–1.60)* 2.27 (2.14–2.40)*
Long-term injury
No Reference Reference Reference
Yes 1.41 (1.32–1.50)* 1.21 (0.94–1.55) 1.43 (1.34–1.53)*
Other long-term conditions
No Reference Reference Reference
Yes 1.79 (1.70–1.88)* 1.63 (1.33–2.00)* 1.80 (1.71–1.90)*
Survey year
2022–2023 Reference Reference Reference
2023–2024 0.78 (0.75–0.82)* 0.79 (0.66–0.94)* 0.78 (0.75–0.81)*

Cancer status

No

Yes

Reference

1.62 (1.46–1.78)*

NA NA

*p-value < 0.05

For the cancer group, the presence of mental health and other long-term health conditions was associated with a higher likelihood of telehealth service use, whereas being unmarried, uninsured, having a lower education level (i.e. certificate or no non-school qualification) and completing the PES survey in a more recent survey were associated with a lower likelihood of telehealth service use. The results were non-significant for other variables in the cancer group.

Self-assessed health status, and use of ED services and hospitalisations

Relative to people without cancer and telehealth use, the odds of reporting poor health status was highest in people with cancer and telehealth use (aOR = 4.29, 95% CI = 3.59–5.12). This was followed by people with cancer who did not use telehealth (aOR = 2.52, 95% CI = 2.18–2.90), and people without cancer who had a telehealth service (aOR = 1.28, 95% CI = 1.20–1.37) (Fig. 1).

Fig. 1.

Fig. 1

Comparison of self-reported health status, visits to emergency departments and hospitalisation by cancer status and use of telehealth. aAdjusted for sociodemographic (sex, age, country of birth, geographical location, marital status, employment status, education level, socioeconomic status, private health insurance status), presence of individual types of long-term health conditions and year of survey. bGood health comprising rating of excellent, very good or good health status and poor health comprising rating of fair or poor health status

The odds of having had an ED visit and a hospital admission in the past 12 months followed these similar trends.

Perceptions of telehealth service use

Among those who had a telehealth service and responded to the questions related to their perceptions of telehealth, the majority of them (86–88%) reported that they would use telehealth again in both cancer and non-cancer groups (Table 3). The majority of people who had a telehealth service reported that the telehealth practitioners always/often listened carefully to them (93–95%), showed respect for what they had to say (95%), and spent enough time with them (91–93%) in both cancer and non-cancer groups. There were no significant differences between cancer and non-cancer groups in their responses to those questions.

Table 3.

Perceptions of telehealth service

Description, n (%) Cancer n = 721 Non-cancer n = 11,303 p-value
Would use telehealth again
Yes 620 (86) 9991 (88) 0.060
No 101 (14) 1312 (12)
Telehealth practitioners listened carefully
Always/often 686 (95) 10,529 (93) 0.046
Sometimes/rarely/never 35 (5) 774 (7)
Telehealth practitioners showed respect
Always/often 686 (95) 10,706 (95) 0.680
Sometimes/rarely/never 35 (5) 597 (5)
Telehealth practitioners spent enough time
Always/often 670 (93) 10,293 (91) 0.101
Sometimes/rarely/never 51 (7) 1010 (9)

Discussion

This cross-sectional study showed a higher prevalence of telehealth service use in people with cancer compared to people without cancer. A higher telehealth use in the cancer group may indicate a higher burden of disease and healthcare needs among people living with cancer. Two factors, including the presence of mental health conditions and other long-term health conditions, were associated with a higher odds of telehealth service use in people with cancer, whereas four other factors including being unmarried, uninsured, having a lower education level and completing PES survey in a more recent year were associated with a lower odds of telehealth service use. Relative to people without both cancer and telehealth use, the odds of reporting poor health status, having had an ED visit and a hospital admission in the past 12 months were highest among people with cancer who used telehealth, followed by people with cancer who did not use telehealth and people without cancer who had a telehealth service. Overall, people who used telehealth showed positive perceptions of the service regardless of cancer status.

Studies using data from the 2022 Health Information National Trends Survey showed that 39–43% of US adults received care from a health professional using telehealth in the past 12 months [18–20], which was higher than the estimates found in our study ranging from 26% in the non-cancer group to 38% in the cancer group. This difference may reflect the types of study population (cancer versus general population) across studies, patient or provider preferences, literacy and access to digital technology and complexity of care across study population [21]. Our study also demonstrated that the proportion of people who had a telehealth service decreased over time in both cancer (from 40% in 2022–23 to 35% 2023–24 survey) and non-cancer groups (from 28 to 24%), similar to that observed in a study among US adult general population (from 37% in 2021 to 30% in 2022) [22] and in oncology practices (33% in 2020 then levelled off to 12–15%) [21] which may be due to patient preferences of returning to in-person care options as the pandemic restrictions eased [23]. While over one-third of the cancer group in our study received telehealth service, the majority did not. Barriers to accessing telehealth services especially in these group of patients with high burden of disease warrant further investigation [24].

Comparable to prior findings [18, 19], the presence of long-term health conditions was identified as predictors of telehealth service use in our study. As comorbidities contribute to a significant healthcare burden, the use of telehealth provides a feasible care option for management of select chronic diseases which have been shown to improve patient outcomes [25] and may also reduce the financial burden associated with time, travel and costs [26]. Our study showed that the presence of mental health conditions, in particular, was associated with significantly higher odds of telehealth service in people with cancer. This result was consistent with the findings of a study conducted in Florida, USA, in the Medicaid beneficiaries which showed that patients needing psychiatric care were highly likely to use telehealth service, albeit in the non-cancer population [27]. Taken together, the findings suggest there may be continued opportunities to integrate telehealth for those who have complex healthcare needs and/or require regular service use to increase access to care.

Our study found several factors including being unmarried, uninsured, having a lower education level and a more recent survey year to be associated with lower odds of telehealth service use in both cancer and non-cancer groups. While telehealth service is covered by the Australian Government’s Medicare Benefits Schedule, it is possible that some Australian residents would have access to the direct-to-consumer telehealth services operating outside of publicly funded Medicare system [28]. Out-of-pocket costs could be a barrier to assessing such service in those without a private health insurance. The two PES were conducted between July 2022-June 2023 and July 2023-June 2024, which may have contributed to differences in findings by survey year in relation to the timing of COVID-19 restrictions. Our findings of the effects of sociodemographic factors including marital status and education level on telehealth service use were consistent with prior studies [20, 29]. Other characteristics associated with decreased odds of telehealth service observed in the general population included older age and male [18, 19, 30, 31], comparable to our findings in the non-cancer group although the results for these variables did not reach statistical significance in the cancer group which may be due to relatively modest sample size. Considerable disparity exists in internet access and digital skills among older adults which may affect their ability to use telehealth services [32]. It is plausible that men may generally be less likely to engage with medical services compared to women due to decreased health seeking behaviours associated with traditional masculine stereotypes [33]. In contrast, other studies found telehealth use was higher among males than females [34, 35], and the gender differences observed across studies may partly reflect variation in disease burden, health-seeking awareness and technology literacy. Investing resources into educating older patients and those with lower level of education attainment and promoting positive masculinity in the context of health and the use of technologies in their care may help improve use of telehealth services in these populations.

The odds of reporting poor health status, having had an ED visit and a hospital admission in the past 12 months were highest in people with cancer and telehealth use, followed by people with cancer who did not use telehealth and people without cancer who had a telehealth service, when compared to people without cancer and telehealth usage. People with cancer had higher healthcare needs [36] and poorer health status [17] than those without cancer and common reasons for presentation to ED and hospitalisation included side effects associated with cancer treatment, infections and cancer disease progression [37–39]. The relationship between telehealth and other health services use appears to be bidirectional. It is plausible that the presence of selected conditions such as cancer prompts presentation to ED and that leads to the introduction of virtual ED as part of the emergency telehealth services [40]. Urgent telehealth visits could also lead to more presentations to ED and some conditions might require urgent physical examinations and/or diagnostic assessment at ED or in the hospital settings following telehealth consultation where remote care could not be delivered effectively [30]. A systematic review included 127 randomised controlled trials examining the effect of telehealth on hospital services found that while small to moderate reductions in hospital service use could be achieved through telehealth, there were uncertainties surrounding the magnitude of the effects as not all differences reached statistical significance [41]. Further longitudinal study is required to examine the effects of telehealth on other health service utilisation in people with cancer and other chronic diseases to identify which aspects of telehealth result in positive and negative outcomes.

Reassuringly, over 90% of people who used telehealth in our study showed positive perceptions of the service regardless of cancer status. Several other studies have also described positive themes surrounding patient satisfaction with telehealth service [42, 43]. Taken together, these findings suggest that telehealth could be a feasible option in healthcare delivery and that the integration of telehealth into cancer models of care to complement in-person care could provide a hybrid approach combining the benefits of both [24, 44]. Further longitudinal study to investigate the effects of telehealth on health outcomes including clinical and patient-reported outcomes is needed to inform the development of health policy and strategies that promote an innovative approach to healthcare delivery.

This study has several limitations. Self-reported data was used in this study which may be subject to recall and response bias [45, 46]. As information on the date of services was not collected in the PES, we were unable to differentiate the sequences of telehealth service in relation to visits to the ED and hospitalisation. We were also not able to perform further subgroup analysis by type of cancer and time from cancer diagnosis and by frequency of telehealth service use as the information was not available in the dataset. It is possible that there may be lower engagement in the surveys among selected populations such as people from culturally and linguistically diverse backgrounds [47]; selected questions in the PES such as perceptions of telehealth service were not asked among those with language barriers. Nonetheless, given that there is limited data on telehealth in people with cancer compared to the general population, our study provided useful insights into the telehealth use in this cohort of people.

Conclusion

While over one-third of people with cancer utilised a telehealth service, the majority did not. A higher odds of ED presentation and hospitalisation in people with cancer who had a telehealth use may reflect greater care needs. Further research should investigate the barriers to accessing telehealth services in these group of people with high disease burden to inform the development of health policy and strategies targeting people with the greatest needs.

Author contributions

All authors contributed to the study conception and design. Data analysis was performed by Huah Shin Ng. The first draft of the manuscript was written by Huah Shin Ng and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Funding

Open Access funding enabled and organized by CAUL and its Member Institutions Huah Shin Ng receives research funding from the Cancer Council South Australia Early Career Research Fellowship. This study was produced with the financial and other support of Cancer Council SA’s Beat Cancer Project on behalf of its donors and the State Government of South Australia through the Department of Health and Wellbeing.

Data availability

The data may be accessed through the Australian Bureau of Statistics with the appropriate approvals.

Declarations

Ethics approval

This study was approved by the Flinders University Human Research Ethics Committee Low Risk Panel (#7218) and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.

Consent to participate

Consent to participate is not required for the secondary analysis of the existing de-identified datasets.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Mechanic OJ PY, Kimball AB. Telehealth Systems. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459384/ [PubMed]
  2. Australian Government Australian Digital Health Agency. Telehealth 2025. Available from: https://www.digitalhealth.gov.au/initiatives-and-programs/telehealth 
  3. Ezeamii VC, Okobi OE, Wambai-Sani H et al (2024) Revolutionizing healthcare: how telemedicine is improving patient outcomes and expanding access to care. Cureus 16(7):e63881. 10.7759/cureus.63881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Australian Government Department of Health and Aged Care (2022) MBS telehealth services from January 2022. Available from: https://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Factsheet-Telehealth-Arrangements-Jan22 . Accessed 8 July 2025
  5. Australian Government Services Australia (2024) Who can claim telehealth services. Available from: https://www.servicesaustralia.gov.au/who-can-claim-telehealth-services-under-mbs-or-dva?context=20. Accessed 4 June 2025
  6. White SJ, Nguyen A, Roger P et al (2022) Experiences of telehealth in general practice in Australia: research protocol for a mixed-methods study. BJGP Open. 10.3399/bjgpo.2021.0187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bradford NK, Caffery LJ, Smith AC (2016) Telehealth services in rural and remote Australia: a systematic review of models of care and factors influencing success and sustainability. Rural Remote Health 16(4):3808 [PubMed] [Google Scholar]
  8. Lopez AM (2024) Telehealth in cancer care: inequities, barriers, and opportunities. Cancer J 30(1):2–7. 10.1097/ppo.0000000000000694 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Toni E, Ayatollahi H (2024) An insight into the use of telemedicine technology for cancer patients during the Covid-19 pandemic: a scoping review. BMC Med Inform Decis Mak 24(1):104. 10.1186/s12911-024-02507-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Walsan R, Harrison R, Braithwaite J et al (2026) Predictors of unplanned emergency department visits and hospitalisations among adults accessing virtual outpatient oncology services in Queensland, Australia. Telemed J e-Health. 10.1177/153056272614407 [DOI] [PubMed]
  11. Sina M, Mitchell R, Walsan R et al (2025) Using virtual models of care for chronic disease management in outpatient services: a systematic review of quality of care outcomes. Telemed J E Health. 10.1089/tmj.2025.0008 [DOI] [PubMed] [Google Scholar]
  12. Australian Bureau of Statistics (2023) Patient experiences methodology, reference period 2022-23 financial year. Available from: https://www.abs.gov.au/methodologies/patient-experiences-methodology/2022-23. Accessed 4 June 2025
  13. Australian Bureau of Statistics (2024) Patient experiences methodology, reference period 2023-24 financial year. Available from: https://www.abs.gov.au/methodologies/patient-experiences-methodology/2023-24. Accessed 4 June 2025
  14. Australian Bureau of Statistics (2021) DataLab. Available from: https://www.abs.gov.au/statistics/microdata-tablebuilder/datalab. Accessed 5 May 2026
  15. Australian Institute of Health and Welfare (2023) Cancer in adolescents and young adults in Australia 2023. Available from: https://www.aihw.gov.au/reports/cancer/cancer-in-adolescents-young-adults-australia-2023/contents/summary . Accessed 4 June 2025
  16. Australian Bureau of Statistics (2018) Census of population and housing: socio-economic indexes for areas (SEIFA), Australia, 2016. Available from: https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/2033.0.55.001~2016~Main%20Features~IRSD~19#:~:text=The%20Index%20of%20Relative%20Socio,only%20measures%20of%20relative%20disadvantage. Accessed 4 June 2025
  17. Ng HS, Roder D, Koczwara B, Vitry A (2018) Comorbidity, physical and mental health among cancer patients and survivors: an Australian population-based study. Asia Pac J Clin Oncol 14(2):e181–e92. 10.1111/ajco.12677 [DOI] [PubMed] [Google Scholar]
  18. Chang E, Penfold RB, Berkman ND (2024) Patient characteristics and telemedicine use in the US, 2022. JAMA Netw Open 7(3):e243354-e. 10.1001/jamanetworkopen.2024.3354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chandrasekaran R (2024) Telemedicine in the post-pandemic period: understanding patterns of use and the influence of socioeconomic demographics, health status, and social determinants. Telemed J E Health 30(2):480–9. 10.1089/tmj.2023.0277 [DOI] [PubMed] [Google Scholar]
  20. Spaulding EM, Fang M, Commodore-Mensah Y et al (2024) Prevalence and disparities in telehealth use among US adults following the COVID-19 pandemic: national cross-sectional survey. J Med Internet Res 26:e52124. 10.2196/52124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yen TWF, Pan IW, Shih YT (2023) Impact of state telehealth policies on telehealth use among patients with newly diagnosed cancer. JNCI Cancer Spectr. 10.1093/jncics/pkad072 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lucas JW, Wang X (2024) Declines in telemedicine use among adults: United States, 2021 and 2022. Natl Health Stat Report 205:1–11 [PubMed] [Google Scholar]
  23. Lee J, Park JS, Wang KN, Feng B, Tennant M, & Kruger E (2022) The use of Telehealth in Australia during the coronavirus (COVID-19) pandemic for medical practitioners: a retrospective epidemiological analysis: Telehealth usage during COVID-19. Asia Pac J Health Manag 17(3). 10.24083/apjhm.v17i3.1433
  24. Annunziata CM, Dahut WL, Willman CL et al (2024) Reflections on the state of telehealth and cancer care research and future directions. JNCI Monogr 2024(64):100–3. 10.1093/jncimonographs/lgae008 [DOI] [PubMed] [Google Scholar]
  25. Ma Y, Zhao C, Zhao Y et al (2022) Telemedicine application in patients with chronic disease: a systematic review and meta-analysis. BMC Med Inform Decis Mak 22(1):105. 10.1186/s12911-022-01845-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Patel KB, Turner K, Alishahi Tabriz A et al (2023) Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw Open 6(1):e2250211-e. 10.1001/jamanetworkopen.2022.50211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hossain M, Dean EB, Kaliski D (2022) Using administrative data to examine telemedicine usage among Medicaid beneficiaries during the coronavirus disease 2019 pandemic. Med Care 60(7):488–95. 10.1097/mlr.0000000000001723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Khanal V, Russell DJ, Wakerman J (2024) The rise of direct-to-consumer telemedicine services in Australia: implications for primary care and future research. Med J Aust 221(5):285-. 10.5694/mja2.52399 [DOI] [PubMed] [Google Scholar]
  29. Lee EC, Grigorescu V, Enogieru I et al (2023) HHS ASPE reports. Updated national survey trends in telehealth utilization and modality (2021-2022): issue brief. Office of the Assistant Secretary for Planning and Evaluation (ASPE). Available from https://www.ncbi.nlm.nih.gov/books/NBK604393/. Accessed 4 June 2025 [PubMed]
  30. Rodriguez JA, Saadi A, Schwamm LH et al (2021) Disparities in telehealth use among California patients with limited English proficiency. Health Aff (Millwood) 40(3):487–95. 10.1377/hlthaff.2020.00823 [DOI] [PubMed] [Google Scholar]
  31. Eberly LA, Kallan MJ, Julien HM et al (2020) Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open 3(12):e2031640. 10.1001/jamanetworkopen.2020.31640 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Alhussein M, Patel B, Liu X (2023) Closing the gap: technology access and telehealth use among older adults in the U.S. Medicare beneficiaries. Telemat Inform Rep 12:100103. 10.1016/j.teler.2023.100103 [Google Scholar]
  33. Himmelstein MS, Sanchez DT (2016) Masculinity impediments: internalized masculinity contributes to healthcare avoidance in men and women. J Health Psychol 21(7):1283–92. 10.1177/1359105314551623 [DOI] [PubMed] [Google Scholar]
  34. Alcaraz KI, Kitchen C, Richards T et al (2025) Patterns of telehealth use across the cancer care continuum and assessment of patient and geographic factors associated with key healthcare outcomes: retrospective study. JMIR Cancer 11:e79956. 10.2196/79956 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rahman S, Amit S, Kafy AA (2022) Gender disparity in telehealth usage in Bangladesh during COVID-19. SSM Ment Health 2:100054. 10.1016/j.ssmmh.2021.100054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ng HS, Koczwara B, Roder D et al (2020) Patterns of health service utilisation among the Australian population with cancer compared with the general population. Aust Health Rev 44(3):470–9. 10.1071/ah18184 [DOI] [PubMed] [Google Scholar]
  37. McKenzie H, Hayes L, White K et al (2011) Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study. Support Care Cancer 19(7):963–9. 10.1007/s00520-010-0913-y [DOI] [PubMed] [Google Scholar]
  38. Numico G, Cristofano A, Mozzicafreddo A et al (2015) Hospital admission of cancer patients: avoidable practice or necessary care? PLoS One 10(3):e0120827. 10.1371/journal.pone.0120827 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van der Meer DM, Weiland TJ, Philip J et al (2016) Presentation patterns and outcomes of patients with cancer accessing care in emergency departments in Victoria, Australia. Support Care Cancer 24(3):1251–60. 10.1007/s00520-015-2921-4 [DOI] [PubMed] [Google Scholar]
  40. Sri-Ganeshan M, Mitra B, Soldatos G et al (2023) Disposition of patients utilising the virtual emergency department service in southeast region of Melbourne (SERVED-1). Emerg Med Australas 35(4):553–9. 10.1111/1742-6723.14157 [DOI] [PubMed] [Google Scholar]
  41. Peters GM, Kooij L, Lenferink A et al (2021) The effect of telehealth on hospital services use: systematic review and meta-analysis. J Med Internet Res 23(9):e25195. 10.2196/25195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sánchez-Guillén L, Lillo-García C, Barber X et al (2024) Patients’ perception of using telehealth for consultation: insights after pandemic and development of an online calculator platform to predict acceptance of remote consultation: the TELEMED international study. Updates Surg 76(5):2031–41. 10.1007/s13304-024-01780-z [DOI] [PubMed] [Google Scholar]
  43. Kong SS, Otalora Rojas LA, Ashour A et al (2021) Ability and willingness to utilize telemedicine among rheumatology patients—a cross-sectional survey. Clin Rheumatol 40(12):5087–93. 10.1007/s10067-021-05759-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Peprah P, Osman S, Mitchell R et al (2025) Outpatient virtual care among people living with and beyond cancer from culturally and linguistically diverse backgrounds in Australia: a protocol for a realist evaluation. Health Expect 28(2):e70235. 10.1111/hex.70235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Althubaiti A (2016) Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc 9:211–7. 10.2147/jmdh.S104807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rosenman R, Tennekoon V, Hill LG (2011) Measuring bias in self-reported data. Int J Behav Healthc Res 2(4):320–32. 10.1504/ijbhr.2011.043414 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Harrison R, Iqbal MP, Chitkara U et al (2024) Approaches for enhancing patient-reported experience measurement with ethnically diverse communities: a rapid evidence synthesis. Int J Equity Health 23(1):26. 10.1186/s12939-024-02107-5 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data may be accessed through the Australian Bureau of Statistics with the appropriate approvals.


Articles from Supportive Care in Cancer are provided here courtesy of Springer

RESOURCES